New approaches for identifying and testing potential new anti-asthma agents-Reference-Cited by-同舟云学术

New approaches for identifying and testing potential new anti-asthma agents

Published:2017-10-31 Issue:1 Volume:13 Page:51-63
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Licari Amelia¹^ORCID,Castagnoli Riccardo¹^ORCID,Brambilla Ilaria¹,Marseglia Alessia¹,Tosca Maria Angela²,Marseglia Gian Luigi¹^ORCID,Ciprandi Giorgio²³^ORCID

Affiliation:

1. Pediatric Clinic, Fondazione IRCCS San Matteo, Pavia, Italy

2. Pediatric Pulmonology and Allergy, IRCCS Istituto Giannina Gaslini, Genoa, Italy

3. Internal Medicine, Ospedale Policlinico San Martino, Genoa, Italy

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2018.1396315

Reference147 articles.

1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

2. Inflammatory biomarkers for asthma endotyping and consequent personalized therapy

3. The immunology of asthma

4. Allergic airway inflammation: key players beyond the Th2 cell pathway

5. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, functional and immunological characteristics of severe bronchial asthma;Russian Journal of Allergy;2023-07-09

2. New approaches in childhood asthma treatment;Current Opinion in Allergy & Clinical Immunology;2023-06-23

3. Pediatric obesity and severe asthma: Targeting pathways driving inflammation;Pharmacological Research;2023-02

4. New options for severe asthma;Meditsinskiy sovet = Medical Council;2022-10-14

5. Omalizumab for the treatment of severe allergic asthma in children: A tale of two;Clinical Case Reports;2022-08